Anticancer Activity of Diosgenin and Its Molecular Mechanism

Chin J Integr Med. 2023 Aug;29(8):738-749. doi: 10.1007/s11655-023-3693-1. Epub 2023 Mar 20.

Abstract

Diosgenin, a steroidal sapogenin, obtained from Trigonella foenum-graecum, Dioscorea, and Rhizoma polgonati, has shown high potential and interest in the treatment of various cancers such as oral squamous cell carcinoma, laryngeal cancer, esophageal cancer, liver cancer, gastric cancer, lung cancer, cervical cancer, prostate cancer, glioma, and leukemia. This article aims to provide an overview of the in vivo, in vitro, and clinical studies reporting the diosgenin's anticancer effects. Preclinical studies have shown promising effects of diosgenin on inhibiting tumor cell proliferation and growth, promoting apoptosis, inducing differentiation and autophagy, inhibiting tumor cell metastasis and invasion, blocking cell cycle, regulating immunity and improving gut microbiome. Clinical investigations have revealed clinical dosage and safety property of diosgenin. Furthermore, in order to improve the biological activity and bioavailability of diosgenin, this review focuses on the development of diosgenin nano drug carriers, combined drugs and the diosgenin derivatives. However, further designed trials are needed to unravel the diosgenin's deficiencies in clinical application.

Keywords: anticancer; biological activity; diosgenin; molecular mechanism; steroidal sapogenin.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Carcinoma, Squamous Cell* / drug therapy
  • Diosgenin* / metabolism
  • Diosgenin* / pharmacology
  • Diosgenin* / therapeutic use
  • Humans
  • Male
  • Mouth Neoplasms* / drug therapy
  • Prostatic Neoplasms* / drug therapy

Substances

  • Diosgenin